Legal Representation
Attorney
Timothy H. Hiebert
USPTO Deadlines
Next Deadline
388 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-08-25)
Due Date
August 25, 2026
Grace Period Ends
February 25, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
12 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Aug 25, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Jun 14, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jun 14, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jun 14, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jun 9, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 9, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 20, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 7, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 6, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 22, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Feb 21, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 19, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy
First Use Anywhere:
Aug 13, 2018
First Use in Commerce:
Aug 13, 2018
Additional Information
Design Mark
The mark consists of a stylized representation of the DNA molecule, between the upper strands of which is a roughly triangular shape.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005